TickrTrends PGNY fair value analysis

Progyny Inc (PGNY) Stock Up 3.6% and Still Undervalued -- GF Score: 94/100

gurufocus.com · 2026-10-20

On October 19, 2026, Progyny Inc (PGNY) shares rose 3.6% to $27.84, amidst a 52-week trading range of $16.10 to $33.07. The stock has shown a year-to-date incre

TickrTrends take: Progyny's recent stock movement and exceptional GF Score of 94 out of 100 align with TickrTrends' undervalued assessment, suggesting the market has not fully priced in the company's fundamental strength. For valuation-focused readers, the combination of strong quality metrics and below-intrinsic-value pricing indicates potential margin of safety in a Healthcare sector company that continues to demonstrate operational excellence. Monitoring whether institutional investors recognize this valuation gap could provide insight into whether the current undervaluation represents a temporary market inefficiency or reflects underlying sector headwinds.

Read the full story at gurufocus.com →

Is PGNY undervalued? See TickrTrends' fair value analysis →